Skip to main content
SpringerLink
Log in

Multiple sclerosis imaging: recent advances

  • Medical Progress in the Journal of Neurology
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

In this review, we summarize advances in knowledge derived from the application of magnetic resonance imaging (MRI)-based techniques to patients with multiple sclerosis (MS) published in the Journal of Neurology over the past year. We highlight the pivotal role played by conventional MRI techniques for a correct and early diagnosis of this condition and the exclusion of alternative disorders. Advanced MR methods have contributed to demonstrating how damage to selected brain structures is related to disease clinical manifestations, thus contributing to overcome the well-known “clinical-radiological” paradox of MS, and ameliorating the understanding of the mechanisms underlying the accumulation of irreversible disability. Finally, we discuss the use of MRI to assess treatment efficacy and optimize therapeutic approaches in this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. The Optic Neuritis Study Group (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65:727–732

    Article  Google Scholar 

  2. Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N (2007) Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol 64:1157–1161

    Article  PubMed  Google Scholar 

  3. Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ (1997) Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 244:76–84

    Article  PubMed  CAS  Google Scholar 

  4. Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH (2012) Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 259:139–146

    Article  PubMed  Google Scholar 

  5. Bot JC, Barkhof F (2009) Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques. Neuroimaging Clin N Am 19:81–99

    Article  PubMed  Google Scholar 

  6. Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144–1150

    Article  PubMed  Google Scholar 

  7. Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, Miller DH, Montalban X, Simon JH, Polman C, Filippi M (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 5:841–852

    Article  PubMed  Google Scholar 

  8. Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139–1151

    Article  PubMed  Google Scholar 

  9. Dalton CM, Miszkiel KA, Barker GJ, MacManus DG, Pepple TI, Panzara M, Yang M, Hulme A, O’Connor P, Miller DH (2004) Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis. J Neurol 251:407–413

    Article  PubMed  CAS  Google Scholar 

  10. Eckstein C, Saidha S, Levy M (2012) A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J Neurol 259:801–816

    Article  PubMed  Google Scholar 

  11. Filippi M, Agosta F, Spinelli EG, Rocca MA (2012) Imaging resting state brain function in multiple sclerosis. J Neurol. doi:10.1007/s00415-012-6695-z

  12. Filippi M, Horsfield MA, Ader HJ, Barkhof F, Bruzzi P, Evans A, Frank JA, Grossman RI, McFarland HF, Molyneux P, Paty DW, Simon J, Tofts PS, Wolinsky JS, Miller DH (1998) Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 43:499–506

    Article  PubMed  CAS  Google Scholar 

  13. Filippi M, Rocca MA, Camesasca F, Cook S, O’Connor P, Arnason BG, Kappos L, Goodin D, Jeffery D, Hartung HP, Comi G, Wolinsky JS, Bogumil T, Pohl C, Beckmann K, Sandbrink R, Croze E, Brown C, Desimone TM, Arnold DL, Cutter G, Knappertz V (2011) Interferon beta-1b and glatiramer acetate effects on permanent black hole evolution. Neurology 76:1222–1228

    Article  PubMed  CAS  Google Scholar 

  14. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15:559–567

    Article  PubMed  CAS  Google Scholar 

  15. Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, Inglese M, Pelletier D, Comi G (2011) Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 68:1514–1520

    Article  PubMed  Google Scholar 

  16. Filippi M, Rovaris M, Rocca MA, Sormani MP, Wolinsky JS, Comi G (2001) Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”. Neurology 57:731–733

    Article  PubMed  CAS  Google Scholar 

  17. Goodin DS (2006) Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment? Ann Neurol 59:597–605

    Article  PubMed  Google Scholar 

  18. Hackmack K, Weygandt M, Wuerfel J, Pfueller CF, Bellmann-Strobl J, Paul F, Haynes JD (2012) Can we overcome the ‘clinico-radiological paradox’ in multiple sclerosis? J Neurol 259:2151–2160

    Article  PubMed  Google Scholar 

  19. Harrison DM, Shiee N, Bazin PL, Newsome SD, Ratchford JN, Pham D, Calabresi PA, Reich DS (2012) Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis. J Neurol. doi:10.1007/s00415-012-6638-8

  20. Havla J, Gerdes LA, Meinl I, Krumbholz M, Faber H, Weber F, Pellkofer HL, Hohlfeld R, Kumpfel T (2011) De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. J Neurol 258:1665–1669

    Article  PubMed  CAS  Google Scholar 

  21. Havrdova E, Galetta S, Hutchinson M, Stefoski D, Bates D, Polman CH, O’Connor PW, Giovannoni G, Phillips JT, Lublin FD, Pace A, Kim R, Hyde R (2009) Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol 8:254–260

    Article  PubMed  Google Scholar 

  22. Hayton T, Furby J, Smith KJ, Altmann DR, Brenner R, Chataway J, Hunter K, Tozer DJ, Miller DH, Kapoor R (2012) Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis. J Neurol 259:237–245

    Article  PubMed  CAS  Google Scholar 

  23. Hayton T, Furby J, Smith KJ, Altmann DR, Brenner R, Chataway J, Hunter K, Tozer DJ, Miller DH, Kapoor R (2012) Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine. J Neurol 259:505–514

    Article  PubMed  CAS  Google Scholar 

  24. Hellwig K, Gold R (2011) Progressive multifocal leukoencephalopathy and natalizumab. J Neurol 258:1920–1928

    Article  PubMed  CAS  Google Scholar 

  25. Hickman SJ, Dalton CM, Miller DH, Plant GT (2002) Management of acute optic neuritis. Lancet 360:1953–1962

    Article  PubMed  CAS  Google Scholar 

  26. Horwitz H, Degn M, Modvig S, Larsson HB, Wanscher B, Frederiksen JL (2012) CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis. J Neurol 259:2616–2620

    Article  PubMed  Google Scholar 

  27. Kapoor R, Furby J, Hayton T, Smith KJ, Altmann DR, Brenner R, Chataway J, Hughes RA, Miller DH (2010) Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol 9:681–688

    Article  PubMed  CAS  Google Scholar 

  28. Kleinfeld K, Mobley B, Hedera P, Wegner A, Sriram S, Pawate S (2012) Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation. J Neurol. doi:10.1007/s00415-012-6680-6

  29. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452

    Article  PubMed  CAS  Google Scholar 

  30. Linda H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C (2009) Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361:1081–1087

    Article  PubMed  CAS  Google Scholar 

  31. Melin A, Outteryck O, Collongues N, Zephir H, Fleury MC, Blanc F, Lacour A, Ongagna JC, Berteloot AS, Vermersch P, de Seze J (2012) Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis. J Neurol 259:1215–1221

    Article  PubMed  CAS  Google Scholar 

  32. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157–1174

    Article  PubMed  CAS  Google Scholar 

  33. Nociti V, Batocchi AP, Luigetti M, Conte A, Lorusso VS, Roiati S, Tartaglione T, Del Grande A, Sabatelli M (2011) Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else? J Neurol 258:1965–1970

    Article  PubMed  Google Scholar 

  34. Ormerod IE, Miller DH, McDonald WI, du Boulay EP, Rudge P, Kendall BE, Moseley IF, Johnson G, Tofts PS, Halliday AM et al (1987) The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quant study. Brain 110(Pt 6):1579–1616

    Google Scholar 

  35. Paling D, Golay X, Wheeler-Kingshott C, Kapoor R, Miller D (2011) Energy failure in multiple sclerosis and its investigation using MR techniques. J Neurol 258:2113–2127

    Article  PubMed  Google Scholar 

  36. Papadopoulou A, von Felten S, Traud S, Rahman A, Quan J, King R, Garren H, Steinman L, Cutter G, Kappos L, Radue EW (2012) Evolution of MS lesions to black holes under DNA vaccine treatment. J Neurol 259:1375–1382

    Article  PubMed  CAS  Google Scholar 

  37. Pardini M, Bonzano L, Mancardi GL, Roccatagliata L (2010) Frontal networks play a role in fatigue perception in multiple sclerosis. Behav Neurosci 124:329–336

    Article  PubMed  Google Scholar 

  38. Patrucco L, Rojas JI, Cristiano E (2012) Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes. J Neurol 259:1317–1320

    Article  PubMed  CAS  Google Scholar 

  39. Polman CH, O’Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899–910

    Article  PubMed  CAS  Google Scholar 

  40. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 69:292–302

    Article  PubMed  Google Scholar 

  41. Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–691

    Article  PubMed  CAS  Google Scholar 

  42. Reilmann R, Holtbernd F, Bachmann R, Mohammadi S, Ringelstein EB, Deppe M (2012) Grasping multiple sclerosis: do quantitative motor assessments provide a link between structure and function? J Neurol. doi:10.1007/s00415-012-6639-7

  43. Riccitelli G, Rocca MA, Forn C, Colombo B, Comi G, Filippi M (2011) Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue. AJNR Am J Neuroradiol 32:874–879

    Article  PubMed  CAS  Google Scholar 

  44. Rieckmann P, Boyko A, Centonze D, Coles A, Elovaara I, Havrdova E, Hommes O, Lelorier J, Morrow SA, Oreja-Guevara C, Rijke N, Schippling S (2012) Future MS care: a consensus statement of the MS in the 21st Century Steering Group. J Neurol. doi:10.1007/s00415-012-6656-6

  45. Rocca MA, Absinta M, Filippi M (2012) The role of advanced magnetic resonance imaging techniques in primary progressive MS. J Neurol 259:611–621

    Article  PubMed  Google Scholar 

  46. Rocca MA, Agosta F, Colombo B, Mezzapesa DM, Falini A, Comi G, Filippi M (2007) fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection. Hum Brain Mapp 28:373–382

    Article  PubMed  Google Scholar 

  47. Sepulcre J, Masdeu JC, Goni J, Arrondo G, Velez de Mendizabal N, Bejarano B, Villoslada P (2009) Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler 15:337–344

    Article  PubMed  CAS  Google Scholar 

  48. Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, Wang H, Bookheimer SY (2008) Regional hippocampal atrophy in multiple sclerosis. Brain 131:1134–1141

    Article  PubMed  CAS  Google Scholar 

  49. Sormani MP, Bonzano L, Roccatagliata L, Cutter GR, Mancardi GL, Bruzzi P (2009) Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach. Ann Neurol 65:268–275

    Article  PubMed  Google Scholar 

  50. Sormani MP, Bonzano L, Roccatagliata L, Mancardi GL, Uccelli A, Bruzzi P (2010) Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-anal approach. Neurol 75:302–309

    CAS  Google Scholar 

  51. Stuve O, Marra CM, Jerome KR, Cook L, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Hemmer B, Monson NL, Racke MK (2006) Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol 59:743–747

    Article  PubMed  CAS  Google Scholar 

  52. Vellinga MM, Castelijns JA, Barkhof F, Uitdehaag BM, Polman CH (2008) Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology 70:1150–1151

    Article  PubMed  CAS  Google Scholar 

  53. Yaldizli O, Glassl S, Sturm D, Papadopoulou A, Gass A, Tettenborn B, Putzki N (2011) Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J Neurol 258:2199–2205

    Article  PubMed  Google Scholar 

  54. Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, Curfman B, Miszkiel K, Mueller-Lenke N, Sanchez E, Barkhof F, Radue EW, Jager HR, Clifford DB (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354:924–933

    Article  PubMed  CAS  Google Scholar 

  55. Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, Filippi M (2012) MRI pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol. doi:10.1002/ana.23676

Download references

Conflicts of interest

The authors declare that they have no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, via Olgettina 60, 20132, Milan, Italy

    Maria A. Rocca, Roberta Messina & Massimo Filippi

Authors
  1. Maria A. Rocca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberta Messina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Filippi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Filippi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rocca, M.A., Messina, R. & Filippi, M. Multiple sclerosis imaging: recent advances. J Neurol 260, 929–935 (2013). https://doi.org/10.1007/s00415-012-6788-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-012-6788-8

Keywords

Search

Navigation